Guwahati NCB Seizes Over 23 Kg Of Tramadol, 2200 Nitrazepam Tablets, Arrests 3 Individuals

Guwahati: In a significant achievement, the Narcotics Control Bureau’s Guwahati Zonal Unit conducted a specialized operation to combat drug trafficking ahead of the upcoming Lok Sabha elections.

They successfully disrupted and dismantled a cross-state network engaged in the illegal distribution of Tramadol and Nitrazepam drugs, operating between Patna, Bihar, and Bokajan, Assam.

The NCB seized 23.340 kg of Tramadol and 2200 tablets of Nitrazepam.

The crackdown was conducted on the basis of reliable input and further continuous surveillance on the ground.

In an official announcement, the NCB, Guwahati Zonal Unit, reported that they arrested an individual named Nitiya Nand Singh from Bihar’s Nalanda, on March 16, 2024, as he was en route to Bokajan, Assam, via Dimapur aboard a train.

“On search, NCB Guwahati team recovered and seized 23.340 kg Tramadol & 2200 tabs Nitrazepam from his possession. The seized contraband was packed in plastic packets and kept inside one luggage bag and one trolley bag. He was arrested subsequently. Source of the contraband was traced to (Bihar) and the destination was Bokajan (Assam). Again, a team of NCB Guwahati was sent to Patna for conducting follow-up action against suspects of the above mentioned seizure. After surveillance for several days, the suspects, namely Vinay Kumar of Patna (Bihar) and Rajni Kant Kumar of Patna (Bihar) were arrested on April 1 at Patna,” an official press release stated. (ANI)

Related Posts

  • Pharma
  • April 26, 2025
  • 148 views
Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Mumbai:  Suven Pharmaceuticals Limited, a contract development and manufacturing organization (CDMO), has announced that it has received final approval from the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers,…

  • Pharma
  • April 26, 2025
  • 112 views
Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

India’s largest diagnostics service provider, Dr Lal PathLabs (DLPL), on Friday reported an 81.4 per cent year-on-year (Y-o-Y) increase in consolidated net profit for the March quarter of financial year…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

250% rally in one year! Multibagger pharma stock jumps despite stock market crash

250% rally in one year! Multibagger pharma stock jumps despite stock market crash